MHNC:NYSEMaiden Holdings North America, Ltd. 7.75% Notes due 2043 Analysis
Data as of 2026-04-17 - not real-time
$12.65
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $12.65, just above its 20‑day SMA (12.38) but below both the 50‑day (13.72) and 200‑day (16.14) averages, signaling a bearish medium‑term bias. RSI sits near the neutral zone at 46 and the MACD histogram is modestly positive (0.11) while the MACD line remains negative, suggesting limited upside momentum.
Support sits at $11.14 and resistance at $13.25; volume is on a decreasing trend and 30‑day volatility is high at roughly 47%. Although beta is extremely low (0.07), the max drawdown of -36% and an “Extreme Greed” market sentiment (FGI 89.39) heighten caution.
Support sits at $11.14 and resistance at $13.25; volume is on a decreasing trend and 30‑day volatility is high at roughly 47%. Although beta is extremely low (0.07), the max drawdown of -36% and an “Extreme Greed” market sentiment (FGI 89.39) heighten caution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price above 20‑day SMA but below longer‑term averages
- Decreasing volume and high short‑term volatility
- Support near $11.14 limiting downside
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Price remains under 50‑day and 200‑day SMAs
- Historical max drawdown of ~36% indicates downside risk
- Lack of earnings or cash flow data
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Absence of fundamental metrics makes valuation uncertain
- Low beta suggests limited market‑wide risk exposure
- Extreme market greed could create speculative upside
Key Metrics & Analysis
Technical Analysis
TrendBearish
RSI46.4
Support$11.14
Resistance$13.25
MA 20$12.38
MA 50$13.72
MA 200$16.14
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta0.07
Volatility46.94%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.